Search

everythinglearnresearchcommunity

for

Search:↓

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Finasteride can slow hair loss and promote growth in postmenopausal women.

Caucasian women's hair appears thickest in their 20s, with perceived thinning after mid-30s due to both decreasing density and diameter.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Most women have a widow's peak and specific hairline features useful for designing hair restoration surgery.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

The study found that family history, personal history of adolescent acne, no pregnancies, hirsutism, office work, stress, and low intake of fruits/vegetables and fish are risk factors for adult female acne.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Obese women with PCOS are more likely to have fatty liver disease.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Nutrafol® Women's Capsules safely and effectively promote hair growth in women with thinning hair.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Healthy women tend to lose more hair in July and April, and the least in February.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Korean women's hair thins, weakens, and greys with age, with mineral and sterol changes.

Experts made a guide to help doctors evaluate women with too much hair growth.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

High BMI worsens hair growth in women with PCOS.